To summarize, our study clearly presents evidence that MAP4K4 promotes SNO-Drp1 by suppressing the expression of GPX4, which induces endothelial ferroptosis and dysfunction and ultimately leads to cardiac microvascular disorders in DCM. The gene discussed is DNM1L; the disease is familial dilated cardiomyopathy.